Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2007
05/23/2007CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses
05/23/2007CN1317278C Heterocyclic compounds and their use as medicines
05/23/2007CN1317029C Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis
05/23/2007CN1317022C Chinese medicine for treating bone fracture
05/23/2007CN1317021C Chinese medicinal formulation for stopping pain for removing Bi
05/23/2007CN1317015C Recovery paste for osteonosus
05/23/2007CN1316997C Preparation for free flowing ginew and bone and its preparation method
05/23/2007CN1316990C Chinese medicinal composition, preparation method and quality control method thereof
05/23/2007CN1316980C Medicinal use of spanish moss of Chinese traditional medicine
05/23/2007CN1316978C Compound glucosamine sulfate dispersible tablet formulation and its preparation method
05/23/2007CN1316971C Pharmaceutical composition with sustained release function and its preparing process
05/23/2007CN1316963C Yunnan begonia herb drip pill and its preparation method
05/23/2007CN1316958C Caulis Erycibes drop-pill and its preparation method
05/23/2007CN1316908C Health-care tea of fructus ligustri lucidi
05/22/2007US7220867 Dissolving with crystal growth inihibitos; drying
05/22/2007US7220856 Substituted quinoline CCR5 receptor antagonists
05/22/2007US7220834 FHIT proteins and nucleic acids and methods based thereon
05/22/2007US7220829 Cytokine binding domain of cytokine receptors
05/22/2007US7220771 Jun n-terminal kinase inhibitors
05/22/2007US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis
05/22/2007US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example
05/22/2007US7220746 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis
05/22/2007US7220739 Therapeutic application of pro-apoptotic benzodiazepines
05/22/2007US7220722 Lipoprotein-regulating medicants
05/22/2007US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening
05/22/2007US7220406 Method for promoting bone formation
05/22/2007CA2174327C Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women
05/18/2007WO2007056433A2 Methods of treating tissue defects
05/18/2007WO2007055418A1 Aza-substituted spiro derivative
05/18/2007WO2007055374A1 Therapeutic agent for osteoporosis
05/18/2007WO2007054309A2 Use of clodronic acid for the treatment of navicular syndrome
05/18/2007WO2007017695A3 Dihydroxyanthraquinones and their use
05/18/2007WO2007013944A3 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
05/18/2007WO2007006544A3 Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
05/18/2007WO2006106438A3 Modulators of ppar activity
05/18/2007CA2629018A1 Aza-substituted spiro derivative
05/18/2007CA2627942A1 Use of clodronic acid for the treating podotrochlosis
05/17/2007US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors
05/17/2007US20070112029 Piperidine compound and process for preparing the same
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/17/2007US20070111946 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
05/17/2007US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
05/17/2007US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
05/17/2007US20070111266 Antibodies to murine zcytor17 ligand
05/17/2007US20070110835 Method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity
05/17/2007US20070110800 Pharmaceutical composition having uniform drug distribution and potency
05/16/2007EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
05/16/2007EP1784391A1 Phenanthridine carbonyl phenols as cytokine expression modulators
05/16/2007EP1784223A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
05/16/2007EP1784182A1 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists
05/16/2007EP1784173A1 Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives
05/16/2007EP1465638B1 Phosphate transport inhibitors
05/16/2007EP1448544B1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/16/2007EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
05/16/2007EP1140136B1 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
05/16/2007CN1964964A Piperidine derivates for the treatment of chemokines mediared disease
05/16/2007CN1964956A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/16/2007CN1964730A Herbal compositions for prevention and treatment rheumatic and inflammatory diseases and method of preparing the same
05/16/2007CN1962641A Metalloproteinase inhibitors
05/16/2007CN1962614A Felbinac acetaminopher ester and its preparation method
05/16/2007CN1961953A Tablet with chain fern and black snake for treating bone disease
05/16/2007CN1961934A Method for preparing Chinese medicinal wine for treating humerus lateral epicondylitis
05/16/2007CN1961933A Hyperosteogeny-resisting formulation for treating orthopaedics disease, preparation method and quality control method thereof
05/16/2007CN1961906A Diterpene extract of Siegesbeckia, its preparation process and use thereof in phamacy
05/16/2007CN1961887A Sustained releasing formulation of compound glucosamine, preparation process and application thereof
05/16/2007CN1961876A Use of phthalimide derivative in preparation of medicament for resisting angiogenesis
05/16/2007CN1961866A Nano-emulsion drug of triperygium wilfordii polycoride and preparation method thereof
05/16/2007CN1961686A Calcium milk biscuit for elderly person
05/16/2007CN1961685A High-calcium yolk biscuit
05/16/2007CN1315869C Osteoporosis resistant estrogen-RGD peptide conjugate and its application in medicine
05/16/2007CN1315839C Benzothiophene [32-b] indole kind derivative, its preparation method and use
05/16/2007CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
05/16/2007CN1315833C Azaindole kinase inhibitors
05/16/2007CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
05/16/2007CN1315537C LIM Mineralization protein splice variants
05/16/2007CN1315527C Externally used cold-evil expelling prepn
05/16/2007CN1315524C Externally applied ointment for treating pains of neck, shoulder, waist and limbs and its preparation process
05/16/2007CN1315520C Externally applied medicine for treating ischemic necrosis of femoral head and its preparation
05/16/2007CN1315507C Externally applied ointment
05/16/2007CN1315488C Specific medicine for treating necrosis of femoral head
05/16/2007CN1315487C Bone strengthening Chinese medicinal preparation for treating osteoporosis and its preparing method
05/15/2007US7217734 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/15/2007US7217732 Cannabinoid receptor agonists
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007US7217694 Inhibitors of IAPP fibril formation and uses thereof
05/15/2007US7217412 IL-17C related mammalian cytokine polypeptides
05/15/2007CA2392973C Benzoimidazole derivatives useful as antiproliferative agents
05/15/2007CA2366186C Retinoid antagonists and use thereof
05/10/2007WO2007053498A1 Compounds useful as antagonists of ccr2
05/10/2007WO2007051805A2 Use of ceacam8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis
05/10/2007WO2007051641A1 Use of calcitonin for the treatment of ra
05/10/2007WO2007029642A9 Remedy for osteoporosis with the use of retinoid x receptor-related compound
05/10/2007WO2007025897A3 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
05/10/2007WO2007023281A3 Biologically active compounds
05/10/2007WO2007002701A3 Anti-inflammatory aryl nitrile compounds
05/10/2007WO2006114387A3 Insp163 polypeptides for the treatment or prevention of cancer and arthritis
05/10/2007US20070105949 Intermediates for the preparation of lipoxin A4 analogs
05/10/2007US20070105936 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability
05/10/2007US20070105933 Amino alcohol compounds
05/10/2007US20070105901 Novel piperidine derivative